Targeted gene therapies for genetic kidney diseases with a 3D drug design platform.
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Seed Helex raised $3.5M in a seed led by pi Ventures for pre-clinical development of its drug against ADPKD. | $3.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.